Vickers Vantage Corp. I (CIK: 0001820190) EDGAR, Information, Filings... CompaniesBIO.Com

Vickers Vantage Corp. I

Mailing address
85 BROAD STREET, 29TH FLOOR, NEW YORK, Cayman Islands, 10004
Phone
(646) 974-8301
State location
New York
State of incorporation
Cayman Islands
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Vickers Vantage Corp. I (CIK: 0001820190) is an American company incorporated in the state of New York. Head office is located at 85 BROAD STREET, 29TH FLOOR, NEW YORK, New York, 10004. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Vickers Vantage Corp. I is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Sorrento Therapeutics, Inc.	0000850261	Nov-10-2022	10 percent owner
SHAH JAISIM	0001242133	Nov-10-2022	director, officer: See Remarks
CZEREPAK ELIZABETH	0001263500	Nov-10-2022	officer: See Remarks
Thompson Tommy G	0001324863	Nov-10-2022	director
Ji Henry	0001470981	Nov-10-2022	director, officer: Executive Chairperson
Followwill Dorman	0001717947	Nov-10-2022	director
Lemus David	0001717972	Nov-10-2022	director
Hamill Laura	0001751804	Nov-10-2022	director
Lee Tien-Li	0001940120	Nov-10-2022	director
Kaji Suneel G	0001743977	Jan-06-2021	director
Myint Steve	0001838625	Jan-06-2021	director
Ho Chris	0001838628	Jan-06-2021	director, 10 percent owner, officer: Chief Financial Officer
Woo Pei Wei	0001838929	Jan-06-2021	director
Vickers Venture Fund VI (Plan) Pte Ltd	0001839160	Jan-06-2021	10 percent owner
Vickers Venture Fund VI Pte Ltd	0001839162	Jan-06-2021	10 percent owner
Chi Jeffrey	0001839163	Jan-06-2021	director, 10 percent owner, officer: Chief Executive Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vickers Vantage Corp. I

Filings	Format	Description	Filed/Effective	File/Film Number
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-25-069295 (33 Act) Size: KB	Apr-01-2025	333-286291 25796436
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-25-047800 (34 Act) Size: KB	Mar-31-2025	001-39852 25793786
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0000950170-25-042756 (33 Act) Size: KB	Mar-20-2025	333-268603 25757337
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0000950170-25-042749 (33 Act) Size: KB	Mar-20-2025	333-275117 25757301
8-K	Document	Current report filing Acc-no: 0000950170-25-042708 (34 Act) Size: KB	Mar-20-2025	001-39852 25756867
8-K	Document	Current report filing Acc-no: 0000950170-25-035963 (34 Act) Size: KB	Mar-10-2025	001-39852 25722365
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-25-047167 (33 Act) Size: KB	Mar-05-2025	333-276245 25710904
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-25-044182 (33 Act) Size: KB	Mar-03-2025	333-275117 25698726
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-25-044174 (33 Act) Size: KB	Mar-03-2025	333-268603 25698667
8-K	Document	Current report filing Acc-no: 0001193125-25-043879 (34 Act) Size: KB	Mar-03-2025	001-39852 25696516
8-K	Document	Current report filing Acc-no: 0001193125-25-043338 (34 Act) Size: KB	Mar-03-2025	001-39852 25693605
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-25-039263 (33 Act) Size: KB	Feb-27-2025	333-275117 25679124
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-25-039254 (33 Act) Size: KB	Feb-27-2025	333-268603 25679006
DEF 14A	Document	Definitive proxy statements Acc-no: 0001193125-25-039223 (34 Act) Size: KB	Feb-27-2025	001-39852 25678729
8-K	Document	Current report filing Acc-no: 0001193125-25-039211 (34 Act) Size: KB	Feb-27-2025	001-39852 25678658
PRER14A	Document	Preliminary revised proxy soliciting materials Acc-no: 0001193125-25-036730 (34 Act) Size: KB	Feb-26-2025	001-39852 25669978
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001193125-25-027244 (34 Act) Size: KB	Feb-14-2025	001-39852 25628052
SCHEDULE 13D/A	Document	Acc-no: 0000950170-25-008501 (34 Act) Size: KB	Jan-23-2025	005-91963 25551441
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-25-008463 ( Act) Size: 0 KB	Jan-23-2025
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001193125-25-009920 (33 Act) Size: KB	Jan-22-2025	333-275117 25543828

Recent 20 filings. View all Vickers Vantage Corp. I filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Vickers Vantage Corp. I overview
Vickers Vantage Corp. I job
Vickers Vantage Corp. I stock
Vickers Vantage Corp. I ownership
Vickers Vantage Corp. I CEO
Vickers Vantage Corp. I documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.